C. Stephens

Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers

Timothy A. Yap, Matthew Krebs, S. Postel-Vinay et al. · European Journal of Cancer · 2016 · 49 citations

Medicine, Oncology, Pharmacology +12

Deep learning–guided design of dynamic proteins

Amy B. Guo, Deniz Akpinaroglu, C. Stephens et al. · Science · 2025 · 47 citations

Life Sciences, Bioengineering, Biophysics +17

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

Martin Maus, Peter Grimminger, Philip C. Mack et al. · Lung Cancer · 2013 · 35 citations · Full text

Medicine, Genetics, Oncology +17

A novel RT-PCR approach to detecting EML4-ALK fusion genes in archival NSCLC tissue.

P. V. Danenberg, C. Stephens, J. Cooc et al. · Journal of Clinical Oncology · 2010 · 13 citations

Medicine, Molecular Biology, Oncology +17